House com­mit­tee grills Emer­gent CEO Bob Kramer over J&J vac­cine de­ba­cle, ill-timed stock sale

With Mary­land CD­MO Emer­gent BioSo­lu­tions still hold­ing for­ma­tion as the FDA mulls over op­er­a­tions at its Bayview Bal­ti­more plant, CEO Bob Kramer has been ham­mered for send­ing mixed mes­sages on the screwup that led to the in­spec­tion in the first place. House lead­ers had some ques­tions for him about that Wednes­day — and it wasn’t pret­ty.

In a con­tentious hear­ing Wednes­day af­ter­noon, mem­bers of the House Sub­com­mit­tee on the Coro­n­avirus Cri­sis grilled Kramer over the state of the Bayview plant and the poor op­tics be­hind his sale of com­pa­ny stock just weeks be­fore news broke that Emer­gent had trashed a batch of John­son & John­son’s Covid-19 vac­cine af­ter an in­gre­di­ents screwup.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER